As pharmaceutical organizations scale their compound libraries into the tens of millions, the performance of their registration infrastructure becomes a critical operational concern. Certara Compound Registration has undergone substantial architectural improvements across recent releases, delivering order-of-magnitude reductions in bulk upload times and predictable throughput at enterprise scale. This white paper presents benchmark data from controlled performance testing across multiple AWS RDS instance classes, large compound databases, and real-world registration scenarios including downstream publishing and project-based access controls. Organizations evaluating Certara’s chemical registration system will find concrete guidance for capacity planning, migration timelines, and version upgrade decisions.
Key Takeaways
- Bulk registration times have improved dramatically across recent releases of Chemaxon Compound Registration.
- Database size scales sub-linearly — larger libraries take proportionally less additional time than expected.
- Higher-tier RDS instances reduce migration time with no application changes required.
- Downstream publishing and project-based access controls have minimal performance impact in current releases of Certara’s chemical registration system
优势
- Informed capacity planning – Right-size your AWS RDS instance based on actual throughput benchmarks.
- Migration confidence – Estimate corporate migration timelines for libraries of any scale before cutover.
- Version upgrade justification – Quantify the performance gains achievable by upgrading to the latest release.
Authors
Dora Nagy, Senior Developer
Zoltan Soki, Software Developer
Csaba Peltz, PhD, MSc, Director of Chemistry
